Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02681198 · ClinicalTrials.gov registry record · Phase 1
Lofexidine Pharmacokinetics in the Presence of Paroxetine in Healthy Volunteers
A Phase 1 study, sponsored by USWM, LLC (dba US WorldMeds).
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
NCT02681198 is a Phase 1 study that has completed, run by USWM, LLC (dba US WorldMeds). The registered enrollment target is 24 participants.
The verdict
NCT02681198, a Phase 1 study, has completed, sponsored by USWM, LLC (dba US WorldMeds).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the pharmacokinetics, safety and tolerability of lofexidine HCl in the presence of paroxetine in healthy adults.
Interventions
- DRUG Paroxetine
- DRUG Lofexidine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2016-01 |
| Est. Completion | 2016-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02681198
The ClinicalTrials.gov registry entry for NCT02681198 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is USWM, LLC (dba US WorldMeds), which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Paroxetine is the first listed.
NCT02681198 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02681198 about?
NCT02681198 is a clinical study titled "Lofexidine Pharmacokinetics in the Presence of Paroxetine in Healthy Volunteers". The purpose of this study is to determine the pharmacokinetics, safety and tolerability of lofexidine HCl in the presence of paroxetine in healthy adults.
What is the current status of trial NCT02681198?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2016-01. Estimated completion is 2016-03.
What interventions are being tested in trial NCT02681198?
The interventions under investigation include: Paroxetine (DRUG), Lofexidine (DRUG).
Who is sponsoring clinical trial NCT02681198?
This trial is sponsored by USWM, LLC (dba US WorldMeds), which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.